Relay Therapeutics
RLAY
#3531
Rank
A$6.01 B
Marketcap
A$27.58
Share price
0.63%
Change (1 day)
398.04%
Change (1 year)

Earnings for Relay Therapeutics (RLAY)

Earnings in 2026 (TTM): -A$0.41 Billion

According to Relay Therapeutics's latest financial reports the company's current earnings are A$10.67 Million. In 2025 the company made an earning of -A$0.4 Billion, an increase over its 2024 earnings that were of -A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Relay Therapeutics from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.41 Billion3.01%
2025 -A$0.4 Billion-18.13%
2024 -A$0.49 Billion-1.25%
2023 -A$0.49 Billion17.72%
2022 -A$0.42 Billion-20.16%
2021 -A$0.53 Billion594.25%
2020 -A$74.91 Million-30.4%
2019 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion-45.03%๐Ÿ‡บ๐Ÿ‡ธ USA